JP Morgan Call 225 PGR 16.08.2024/ DE000JK0MAV7 /

2024-05-24 9:22:37 AM	Chg.-0.090	Bid10:00:37 PM	Ask10:00:37 PM	Underlying	Strike price	Expiration date	Option type
0.410EUR	-18.00%	- Bid Size: -	- Ask Size: -	Progressive Corporat...	225.00 USD	2024-08-16	Call

GlobeNewswire 05-25 Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b OR...

GlobeNewswire 05-24 Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Act...

GlobeNewswire 05-24 BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024

GlobeNewswire 05-23 Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Adv...

GlobeNewswire 05-21 Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data ...

GlobeNewswire 05-20 Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imagi...

TeleTrader 05-20 Yellen says US against tax on billionaires

GlobeNewswire 05-20 APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau)...

GlobeNewswire 05-20 Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Tria...

GlobeNewswire 05-20 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...

GlobeNewswire 05-16 BMW unveils The BMW XM Mystique Allure, a one-of-a-kind luxury vehicle inspired by the iconic superm...

GlobeNewswire 05-15 Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III P...

TeleTrader 05-15 Slovakian opposition denies connection to Fico's attack

GlobeNewswire 05-15 Progressive Reports April 2024 Results

GlobeNewswire 05-14 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment...

GlobeNewswire 05-13 Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...

GlobeNewswire 05-13 BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...

GlobeNewswire 05-13 Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...

GlobeNewswire 05-09 Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...

GlobeNewswire 05-09 Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...

GlobeNewswire 05-08 Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...

GlobeNewswire 05-07 MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-1...

GlobeNewswire 05-06 Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...

GlobeNewswire 05-04 The National Fire Sprinkler Association's Class of 2024: Honoring Fire Sprinkler Industry Greats

GlobeNewswire 05-02 PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Targ...